Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70
Main Authors: | Zobywalski, Anke, Javorovic, Miran, Frankenberger, Bernhard, Pohla, Heike, Kremmer, Elisabeth, Bigalke, Iris, Schendel, Dolores J |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2007
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1858682/ |
Similar Items
-
NOD/scid IL-2Rgnull mice: a preclinical model system to evaluate human dendritic cell-based vaccine strategies in vivo
by: Spranger, Stefani, et al.
Published: (2012) -
Limitations for TCR gene therapy by MHC-restricted fratricide and TCR-mediated hematopoietic stem cell toxicity
by: Schendel, Dolores J., et al.
Published: (2013) -
CD86 and IL-12p70 Are Key Players for T Helper 1 Polarization and Natural Killer Cell Activation by Toll-Like Receptor-Induced Dendritic Cells
by: Lichtenegger, Felix S., et al.
Published: (2012) -
Next-generation dendritic cells for immunotherapy of acute myeloid leukemia
by: Schnorfeil, Frauke, et al.
Published: (2014) -
P55. Dendritic cell vaccination for postremission therapy in AML
by: Lichtenegger, FS, et al.
Published: (2014)